These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 1895044

  • 21. The effects of slow-release verapamil on blood pressure and cardiovascular system in essential hypertension.
    Meric M, Adalet K, Erzengin F, Korkut F, Okur O, Büyüköztürk K.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S42-4. PubMed ID: 2475684
    [Abstract] [Full Text] [Related]

  • 22. Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension.
    Malatino LS, Stancanelli B, Greco G, Polizzi G, Assogna G, Zanna C, Tamburino G.
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():123-6. PubMed ID: 2285642
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB, Borhani N, DeQuattro V, Kaihlanen PM, Oishi S, Due DL, Sirgo MA.
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [Abstract] [Full Text] [Related]

  • 25. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H, Distler A, Michaelis J, Philipp T, Wellek S.
    BMJ; 1989 Oct 07; 299(6704):881-6. PubMed ID: 2510877
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril.
    Holwerda NJ, Fogari R, Angeli P, Porcellati C, Hereng C, Oddou-Stock P, Heath R, Bodin F.
    J Hypertens; 1996 Sep 07; 14(9):1147-51. PubMed ID: 8986917
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 07; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
    Di Somma S, Carotenuto A, de Divitiis M, Paulucci A, Galderisi M, Cuocolo A, de Divitiis O.
    J Hum Hypertens; 1995 Mar 07; 9(3):163-8. PubMed ID: 7783096
    [Abstract] [Full Text] [Related]

  • 33. Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril.
    Forette F, Handfield-Jones R, Henry-Amar M, Fouchard M, Bouchacourt P, Hervy MP, Henry JF, Billaud-Mesguish E, Alexandre JM.
    Gerontology; 1987 Mar 07; 33 Suppl 1():9-16. PubMed ID: 2831117
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S, Serradimigni A.
    J Hum Hypertens; 1989 Jun 07; 3 Suppl 1():29-33. PubMed ID: 2550643
    [Abstract] [Full Text] [Related]

  • 37. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril.
    Breed JG, Ciampricotti R, Tromp GP, Valster FA, Lageweg E, Van Bortel LM.
    J Cardiovasc Pharmacol; 1992 Jun 07; 20(5):750-5. PubMed ID: 1280737
    [Abstract] [Full Text] [Related]

  • 38. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM, Latham AN, Mee F, Atkins N, O'Brien ET, O'Malley K.
    J Cardiovasc Pharmacol; 1989 Jun 07; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [Abstract] [Full Text] [Related]

  • 39. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA, Hals O, Lauve O.
    J Clin Hypertens; 1986 Sep 07; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
    Shankar PK, Vidyasagar S, Adiga S, Naidu MU, Usha Rani P, Rao D, Bairy KL, Nair S, Jayaprakash B, Shashikiran U, Mukhyapranaprabhu.
    Indian J Physiol Pharmacol; 2006 Sep 07; 50(4):421-6. PubMed ID: 17402274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.